Clinical Safety

How Does Relational Safety Impact Ketamine-Assisted Therapy?
Management & Regulatory How Does Relational Safety Impact Ketamine-Assisted Therapy?

Clinicians face a heightened fiduciary obligation because ketamine temporarily impairs a patient’s ability to self-advocate or physically refuse treatment during the peak phase of its effects. This shift represents a radical departure from the conventional administration of SSRIs or other

New Clinical Process Developed for FAP-Targeting PET Tracers
Tech & Innovation New Clinical Process Developed for FAP-Targeting PET Tracers

To combat the risks of radiolysis during high-activity production runs, the final formulation of the tracer now includes a 10 milligram per milliliter concentration of ascorbic acid. This critical adjustment ensures that the molecular integrity of the tracer remains intact even when using higher

What Is the Future of JAK Inhibitors in Immune Disease Treatment?
Research & Development What Is the Future of JAK Inhibitors in Immune Disease Treatment?

Evidence from the RA-BEAM and SELECT-COMPARE trials indicates that certain JAK inhibitors can outperform tumor necrosis factor inhibitors in treating rheumatoid arthritis, a landmark finding that has accelerated the transition from traditional injectable biologics to oral small-molecule therapies.

What Is Mosunetuzumab and How Does It Treat Follicular Lymphoma?
Research & Development What Is Mosunetuzumab and How Does It Treat Follicular Lymphoma?

Because mosunetuzumab targets CD20-positive cells, it is essential for clinicians to confirm the biomarker expression on malignant B cells before initiating the immunotherapy. This diagnostic step ensures that patients with relapsed or refractory follicular lymphoma are appropriate candidates for

Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?
Research & Development Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?

The ethical use of healthy, full-term placental tissue provides a unique source of stem-like cells possessing vital immunomodulatory properties for patient safety, and this therapeutic approach has recently gained significant traction as a viable solution for one of the most stubborn challenges in

New Drug Combinations Tackle Tough Co-Infections Effectively
Research & Development New Drug Combinations Tackle Tough Co-Infections Effectively

Recent investigations into clinical isolates have revealed that over half of Pseudomonas aeruginosa strains and three-quarters of Staphylococcus aureus strains exhibit multidrug resistance in hospital settings. This startling reality underscores a burgeoning crisis in modern healthcare, where

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later